(Q44023399)

29 November 2017

Effect of renal replacement therapy on cellular cytokine production in patients with renal disease (English)

1 reference

29 November 2017

Kimmel PL

1

1 reference

29 November 2017

Phillips TM

series ordinal

2

1 reference

29 November 2017

Phillips E

series ordinal

3

1 reference

29 November 2017

Bosch JP

series ordinal

4

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 July 1990

1 reference

29 November 2017

1 reference

29 November 2017

38

1 reference

29 November 2017

1

1 reference

29 November 2017

129-135

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.1990.177

29 November 2017

0 references

cites work

Human interleukin-1 production during hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.177

7 January 2021

Detection of endotoxin-like interleukin-1-inducing activity during in vitro dialysis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.177

7 January 2021

Enhancement of in-vitro human interleukin-1 production by sodium acetate

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.177

7 January 2021

Cuprammonium membranes stimulate interleukin 1 release and arachidonic acid metabolism in monocytes in the absence of complement

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.177

7 January 2021

The role of dialysate in the stimulation of interleukin-1 production during clinical hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.177

7 January 2021

In vivo induction of interleukin-1 during hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.177

7 January 2021

Blood-membrane interaction in hemodialysis leads to increased cytokine production

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.177

7 January 2021

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.177

7 January 2021

Effect of interleukin-2 and methylprednisolone on in vitro transformation of uremic lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.177

7 January 2021

Kinetic analysis of interleukin 2 (IL-2) production and expression of IL-2 receptors by uraemic and normal lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.177

7 January 2021

Impaired cellular immune responses in chronic renal failure: evidence for a T cell defect

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.177

7 January 2021

Presence of preactivated T cells in hemodialyzed patients: their possible role in altered immunity

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.177

7 January 2021

Enzyme immunoassay ELISA and EMIT

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.177

7 January 2021

https://api.crossref.org/works/10.1038%2FKI.1990.177

1 reference

7 January 2021

https://api.crossref.org/works/10.1038%2FKI.1990.177

1 reference

7 January 2021

The functional relationship of the interleukins

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.177

7 January 2021

Interleukin 2: the molecule and its function

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.177

7 January 2021

Interleukin 2 regulates its own receptors

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.177

7 January 2021

Interleukin 2 production by peripheral blood lymphocytes in allograft recipients during acute rejection episodes

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.177

7 January 2021

Evaluation of the in vitro production of interferon gamma and other lymphokines in uremic patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.177

7 January 2021

Physical activity and employment status of patients on maintenance dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.177

7 January 2021

The quality of life of patients with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.177

7 January 2021

The progression of renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.177

7 January 2021

Identifiers

DOI

10.1038/KI.1990.177

1 reference

Dimensions Publication ID

29 November 2017

1027109210

0 references

Fatcat ID

release_oxv5b33ss5e25by427myso7tqu

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/oxv5b33ss5e25by427myso7tqu

24 November 2022

mapped directly with Wikidata item

1 reference